150 related articles for article (PubMed ID: 19176543)
21. The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten.
Liang X; Daikoku T; Terakawa J; Ogawa Y; Joshi AR; Ellenson LH; Sun X; Dey SK
PLoS Genet; 2018 Aug; 14(8):e1007630. PubMed ID: 30142194
[TBL] [Abstract][Full Text] [Related]
22. Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy.
DeManno D; Elger W; Garg R; Lee R; Schneider B; Hess-Stumpp H; Schubert G; Chwalisz K
Steroids; 2003 Nov; 68(10-13):1019-32. PubMed ID: 14667995
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of progesterone receptor modulators and their effect on the endometrium.
Spitz IM
Curr Opin Obstet Gynecol; 2009 Aug; 21(4):318-24. PubMed ID: 19602929
[TBL] [Abstract][Full Text] [Related]
24. A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.
Madauss KP; Grygielko ET; Deng SJ; Sulpizio AC; Stanley TB; Wu C; Short SA; Thompson SK; Stewart EL; Laping NJ; Williams SP; Bray JD
Mol Endocrinol; 2007 May; 21(5):1066-81. PubMed ID: 17356170
[TBL] [Abstract][Full Text] [Related]
25. The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women.
Chwalisz K; Elger W; Stickler T; Mattia-Goldberg C; Larsen L
Hum Reprod; 2005 Apr; 20(4):1090-9. PubMed ID: 15665012
[TBL] [Abstract][Full Text] [Related]
26. Expression of proliferative and preapoptotic molecules in human myometrium and leiomyoma throughout the menstrual cycle.
Kayisli UA; Berkkanoglu M; Kizilay G; Senturk L; Arici A
Reprod Sci; 2007 Oct; 14(7):678-86. PubMed ID: 18000229
[TBL] [Abstract][Full Text] [Related]
27. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
28. Changes in endometrial PTEN expression throughout the human menstrual cycle.
Mutter GL; Lin MC; Fitzgerald JT; Kum JB; Eng C
J Clin Endocrinol Metab; 2000 Jun; 85(6):2334-8. PubMed ID: 10852473
[TBL] [Abstract][Full Text] [Related]
29. The immunohistochemical profile of atypical eosinophilic syncytial changes vs serous carcinoma.
Haley SL; Malhotra RK; Qiu S; Eltorky ME
Ann Diagn Pathol; 2011 Dec; 15(6):402-6. PubMed ID: 21855381
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of PTEN (phosphatase and tensin homologue deleted on chromosome ten) protein is enhanced in human fibromyomatous uteri.
Kovács KA; Lengyel F; Vértes Z; Környei JL; Gocze PM; Sumegi B; Szabó I; Vértes M
J Steroid Biochem Mol Biol; 2007 Feb; 103(2):196-9. PubMed ID: 17097286
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
Wang J; Ohara N; Takekida S; Xu Q; Maruo T
Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
[TBL] [Abstract][Full Text] [Related]
32. 17beta-estradiol induces up-regulation of PTEN and PPARgamma in leiomyoma cells, but not in normal cells.
Jeong YJ; Noh EM; Lee YR; Yu HN; Jang KY; Lee SJ; Kim J; Kim JS
Int J Oncol; 2010 Apr; 36(4):921-7. PubMed ID: 20198337
[TBL] [Abstract][Full Text] [Related]
33. Postcoital administration of asoprisnil inhibited embryo implantation and disturbed ultrastructure of endometrium in implantation window in mice.
Wu XL; Yu ZH; Qiu J; Yang YH; Shen XL; Su P
J Huazhong Univ Sci Technolog Med Sci; 2013 Apr; 33(2):277-283. PubMed ID: 23592144
[TBL] [Abstract][Full Text] [Related]
34. Endometrial and myometrial expression of nitric oxide synthase isoforms in pre- and postmenopausal women.
Khorram O; Garthwaite M; Magness RR
J Clin Endocrinol Metab; 1999 Jun; 84(6):2226-32. PubMed ID: 10372735
[TBL] [Abstract][Full Text] [Related]
35. Quercetin and indole-3-carbinol inhibit extracellular matrix expression in human primary uterine leiomyoma cells.
Greco S; Islam MS; Zannotti A; Delli Carpini G; Giannubilo SR; Ciavattini A; Petraglia F; Ciarmela P
Reprod Biomed Online; 2020 Apr; 40(4):593-602. PubMed ID: 32276890
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical studies on the proliferative marker Ki-67 and estrogen receptor alpha (ERα) in the uterus of neonatal and immature pigs following exposure to flutamide.
Knapczyk-Stwora K; Durlej M; Bilinska B; Slomczynska M
Acta Histochem; 2011 Sep; 113(5):534-41. PubMed ID: 20598360
[TBL] [Abstract][Full Text] [Related]
37. Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium.
Catherino WH; Malik M; Driggers P; Chappel S; Segars J; Davis J
J Steroid Biochem Mol Biol; 2010 Oct; 122(4):279-86. PubMed ID: 20493256
[TBL] [Abstract][Full Text] [Related]
38. Utility of thin-layer preparations in endometrial cytology: immunocytochemical expression of PTEN, beta-catenin and p53 for benign endometrial lesions.
Norimatsu Y; Miyamoto T; Kobayashi TK; Oda T; Moriya T; Yanoh K; Miyake Y; Ohno E
Diagn Cytopathol; 2008 Apr; 36(4):216-23. PubMed ID: 18335551
[TBL] [Abstract][Full Text] [Related]
39. Tissue differences in the expression of mRNAs of Ha-ras, c-myc, fos and jun in human uterine endometrium, myometrium and leiomyoma under the influence of estrogen/progesterone.
Fujimoto J; Hori M; Ichigo S; Nishigaki M; Tamaya T
Tumour Biol; 1994; 15(6):311-7. PubMed ID: 7997802
[TBL] [Abstract][Full Text] [Related]
40. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
